Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2018

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. CCH:LN
5. META
6. CCHGY
7. PRY:IM
8. PRYMY
9. SKA-B
10. PBA

Go back to Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2018

Array Biopharma (ARRY) Misses Q4 EPS by 1c, Revenues Miss

August 14, 2018 8:01 AM EDT

Array Biopharma (NASDAQ: ARRY) reported Q4 EPS of ($0.25), $0.01 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $35.44 million versus the consensus estimate of $38.73 million.

"We were thrilled to launch BRAFTOVI + MEKTOVI® for patients with BRAF-mutant melanoma in... More